stockrow
Friday 6 November 2026
Export WAT’s income statement to Excel — free account
Waters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024.
- Revenue
- +120.9%
- EPS
- −67.0%
- Free cash flow
- −66.7%
- Total debt
- +308.2%
Quarter to September 2026, against a year earlier
460.68
7.60
+1.68%
Follow WAT
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 2 | 5 |
+8 more TTM periods Free account |
| 0.00% | 1.92% | 5.21% | 29.27% | ||
| 0.68% | 1.13% | 3.09% | 13.35% | ||
ROIC |
1.13% | 1.05% | 1.92% | 17.17% | |
Return on Tangible Assets |
(33.57%) | 4.69% | 13.58% | 41.43% | |
Average Days of Receivables |
95.23 | 156.16 | 169.71 | 95.59 | |
Free Cash Flow per Share |
2.63 | 3.73 | 2.82 | 8.53 | |
Free Cash Flow |
258.37 | 366.60 | 231.60 | 507.60 | |
Capital Expenditures |
(202.19) | (182.96) | (157.96) | (144.96) | |
| Other line items | |||||
Cash ROIC |
1.63% | 1.78% | 1.12% | 12.39% | |
Accounts Receivable Turnover |
5.07 | 3.42 | 3.06 | 4.05 | |
Accounts Payable Turnover |
0.00 | 4.75 | 4.80 | 12.64 | |
Inventory Turnover |
2.99 | 2.38 | 1.68 | 2.46 | |
Average Days of Payables |
0.00 | 138.11 | 129.95 | 29.45 | |
Days of Inventory on Hand |
170.64 | 220.36 | 322.94 | 161.99 | |
Tax Rate |
(0.09) | (0.19) | (0.14) | (0.15) | |
Research and Development Expense of Revenue |
6.59% | 6.84% | 6.49% | 6.18% | |
Selling, General and Administrative Expense of Revenue |
25.56% | 26.92% | 27.67% | 26.23% | |
Share Based Compensation of Revenue |
1.45% | 1.57% | 1.62% | 1.71% | |
Interest Coverage |
1.52 | 2.22 | 5.83 | 11.54 | |
Operating CF/Net income |
4.67 | 3.30 | 0.87 | 1.02 | |
Depreciation/Fixed assets |
0.59 | 0.41 | 0.24 | 0.32 | |
Capex/Depreciation |
(0.23) | (0.30) | (0.43) | (0.70) | |
Revenue per Share |
57.11 | 47.29 | 45.90 | 53.19 | |
Operating CF per Share |
4.69 | 5.60 | 4.74 | 10.97 | |
Capex per Share |
(2.06) | (1.86) | (1.92) | (2.44) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.05 |
Columns are period end dates · fundamentals updated 5 Nov 2026